Great Lakes Drug Metabolism and Disposition Group

About Us

About the GLDMDG

About Us


Our Purpose

The purpose of the Great Lakes Drug Metabolism and Disposition Group (GLDMDG) is to facilitate interactions among scientists interested in all aspects of drug metabolism and disposition. In its eleventh year of existence, the GLDMDG organizes meetings to promote the collegial exchange of ideas on current topics of interest to its members.

We believe the potential benefits of this organization includes:

  • Providing opportunities for graduate students, postdoctoral fellows and senior level associates from regional universities to meet pharmaceutical scientists and pharmacologists from various academic and industrial backgrounds.

  • Promoting regional visibility of the discipline of drug metabolism and disposition science.

  • Facilitating informal dialogue between pharmaceutical partners and academic laboratories to discuss current challenges and emerging opportunities.

  • Enriching interdisciplinary collaboration opportunities for those interested in drug metabolism and disposition.

Steering Committee

  • Dan Albaugh, Covance

  • Buyun Chen, Genentech

  • Laura Furge, Kalamazoo College

  • Stephen D. Hall, Eli Lilly

  • Gary Jenkins, AbbVie

  • Young Jeong, University of Illinois at Chicago

  • Howard Miller, Vertex Pharmaceuticals

  • Yoichi Osawa, University of Michigan

  • Richard Slauter, Charles River Labs

  • Richard Voorman, RMLV

  • Joe Ware, Acerta Pharma

  • Matthew J. Zaya, Zoetis


Sponsorship Opportunities

Interested in becoming a sponsor of the 2019 meeting?  Information about the sponsorship levels and benefits for this year’s meeting can be found in the 2019 GLDMDG Sponsorship Prospectus.